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Background: To clarify the factors associated with post-hepatectomy surgical site infections (SSIs), the
clinicopathological data of 526 patients who underwent hepatectomy was retrospectively examined as a
retrospectively cohort study.
Methods: Patient demographics, liver functions, histological ﬁndings, surgical records and post-
hepatectomy morbidity were compared between non-SSI and SSI groups; the SSI group included su-
perﬁcial and deep SSIs.
Results: The prevalence of SSIs (5e8%) has not changed over an 18-year period. Deep SSIs were signif-
icantly more increased in male patients with lower performance statuses and American Society of An-
esthesiologists (ASA) scores (p < 0.05). SSIs tended to be less prevalent, although not signiﬁcant
(p ¼ 0.10), in patients who underwent laparoscopic hepatectomies compared to those who underwent
laparotomies. For patients in whom hemostatic devices were used, the prevalence of superﬁcial SSIs was
signiﬁcantly lower than those in whom the devices were not used (p < 0.05). Blood loss and transfusion
were signiﬁcantly more frequent in the deep SSI group compared to other groups (p < 0.01). Hospital
stay in the deep SSI group was signiﬁcantly longer compared to other groups. The incidence of morbidity
was more frequent in the SSI groups compared with the non-SSI group (p < 0.001). A multivariate
analysis showed that not using a vessel sealing device was signiﬁcantly associated with superﬁcial SSIs;
male gender, hepatic failure and bile leakage were signiﬁcantly associated with deep SSIs (p < 0.05).
Conclusions: SSIs were important indicators of patient outcomes after hepatectomies, and preventing SSI
development after surgical procedures is an important step in improving the overall prevalence of SSIs.
 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Hepatic resection is an invasive operation that can lead to
increased blood loss requiring red cell transfusions and that can
cause severe physiological stress responses, postoperative compli-
cations (e.g., hepatic failure, bile duct leakage, or multi-organ fail-
ure). Recently, by understanding pathophysiology and the
treatments based on it, perioperative patient management has
gradually improved, along with surgical techniques, which have
been aided by improved surgical skills and medical devices.
Regardless of the improvements in hepatic surgery, hepatectomy-
related surgical site infections (SSIs) have not been eradicated [1].þ81 958197306.
nashima).
by Elsevier Ltd. All rights reservedSSIs in deep lesions affecting the organ were supposedly caused by
the following factors: 1) collections of ﬂuids, such as bile, pancreas
juice, and clotted blood; 2) iatrogenic instruments, such as drainage
tubes, tied knots or staples; 3) organ damage, such as necrotic or
ischemic areas; and 4) bacterial translocation because of hepatic
dysfunction. The incisional SSI in the superﬁcial lesion of the
abdominal wall may be caused by the following: 1) exposure of
digestive tract ﬂuid or blood; 2) bacterial ﬂora, which is usually
located on the patient’s skin; and 3) an exposure to extrinsic bac-
teria. It is important to clarify the hepatectomy-associated param-
eters with SSI in the deep and superﬁcial lesion and then to take the
necessary measures to avoid infections by recognizing the associ-
ated factors. Several investigators have reported on the factors
associated with SSI in patients who underwent hepatectomies [1e
5]. The intent of the present study was to examine these additional
parameters by looking at the temporal trends at a single Japanese.
Table 1
Changes of prevalence of SSI in the different periods.
Term 1
(n ¼ 137)
Term 2
(n ¼ 211)
Term 3
(n ¼ 178)
Statistics
(p value)
Superﬁcial SSI (n ¼ 32) 8 (2%) 9 (2%) 15 (3%) 0.229
Deep SSI (n ¼ 74) 16 (3%) 32 (6%) 26 (5%) 0.637
Total 24 (5%) 41 (8%) 41 (8%) 0.455
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measures to reduce the prevalence of SSI. It was hypothesized that
hepatectomy-related SSI could be improved by treating the risk
factors clariﬁed by the present study.
In the present cohort study, the perioperative clinical and
pathological parameters, surgeon experiences, surgical records and
the postoperative morbidity and mortality rates of 526 patients
with various liver diseases who underwent hepatic resections be-
tween 1994 and 2012 were retrospectively examined. In the 2000s,
a chief operator was changed, although the ﬁrst author treated the
same group for the entire study period. In 2007, we started using
hemostatic devices and the hanging maneuver systematically.
Therefore, the study period was divided into three groups: group 1
(1994e1999), group 2 (2000e2006) and group 3 (2007e2012).
Based on the results, the future strategies for SSIs in liver surgery at
our institute were considered.
2. Materials and methods
2.1. Patient demographics
A total of 526 consecutive patients (367 males, 159 females) undergoing hepatic
resection in the Division of Surgical Oncology and Department of Surgery at Naga-
saki University Graduate School of Biomedical Sciences (NUGSBS) between 1994 and
2012 were analyzed. The mean and median patient ages at the time of surgery were
64.3  11.7 and 67 years (range, 20e86 years), respectively. All patients’ in-hospital
data was consecutively collected during these follow-up periods but no potential
bias. There were no patient selection or matching criteria, and all patients were
enrolled for the present study.
The subjects were divided based on time periods: term 1, hepatectomies
performed between 1994 and 1999, 137 patients (26%); term 2, hepatectomies
performed between 2000 and 2006, 211 patients (40%); and term 3, hepatec-
tomies performed between 2007 and 2012, 178 patients (34%). All of the pa-
tients underwent ICG testing to evaluate the operative indications. All of the
study protocols were approved by the Human Ethics Review Board of our
institution. Informed consent for data collection was obtained from each patient
during this period. Anesthetic and patient data were retrieved from the NUGSBS
database. There was no conﬂict of interests and no ﬁnancial supports from
anywhere.
For hepatectomy, the liver volume to be resected was estimated according to
results of the indocyanine green retention rate at 15 min (ICGR15). Furthermore,
hepatic function for hepatectomy was limited to ICGR15 < 40%. The expected liver
volume for resection, excluding the tumor, was measured by computed tomogra-
phy (CT) volumetry. Functional liver volume by 99mTc-galactosyl serum albumin
(GSA) scintigraphy has been performed in patients since 1998. The liver uptake
ratio at 15 min (LHL15) by 99mTc-GSA scintigraphy and serum hyaluronic acid level
was examined preoperatively [5]. Parenchymal dissection was accomplished using
the forceps fracture method under intermittent vascular clamping of the hepatic
artery and portal vein in the hepatoduodenal ligament. In case of laparoscopic
hepatectomy, forceps fracture method was sometimes applied and, however, the
use of the surgical devices as the ultrasonic dissectors or vessel sealers to dissect
hepatic parenchyma. An evaluation of background liver disease and main liver
disease was conﬁrmed by histopathological examination of the resected specimen.
The classiﬁcation system of the General Rules for the Clinical and Pathological
Study of Primary Liver Cancer for clinic-pathological parameters or the Liver
Damage Grade classiﬁcation was used in the present study [6]. The main operator
was the teaching staff in 361 (69%) cases and the fellowship or resident surgeon in
165 (31%) cases. The operative procedures included hemi-hepatectomies (with
varying degrees of resection) (n ¼ 197, 38%), sectionectomies or segmentectomies
(n ¼ 161, 31%) and partial resection (n ¼ 168, 32%). All of the hepatic tumors were
completely resected without macroscopic exposure of the amputated section to the
remaining liver.
2.2. Statistics
All continuous data are expressed as the mean  SD and median value. Differ-
ences were examined using a one-way analysis of variance (ANOVA) and Student’s t-
test. Correlations between the two parameters were examined by calculating the
Pearson’s correlation coefﬁcient. Categorical data were analyzed using Fisher’s exact
test, which was the most sensitive analysis. Potentially predictive variables were
identiﬁed using a signiﬁcance level of p < 0.05 by univariate analysis, and the
identiﬁed factors were then entered into the multiple logistic regression analysis. A
two-tailed value of P < 0.05 was considered statistically signiﬁcant. SPSS for Win-
dows version 18.0 (SPSS, an IBM Company, Chicago, IL) was used for all the statistical
analyses.3. Results
There were 257 patients (49%) with normal livers, steatohepa-
titis in 17 (3%), chronic hepatitis in 223 (42%), including liver
cirrhosis in 82, and obstructive biliary jaundice in 29 patients (6%).
The following liver diseases were identiﬁed: liver metastasis in 166
(32%), hepatocellular carcinoma (HCC) in 228 patients (43%),
intrahepatic cholangiocarcinoma (ICC) in 38 (8%), gallbladder car-
cinoma in 25 (5%), extrahepatic bile duct carcinoma in 41 (8%), and
other benign liver diseases in 28 (4%). Regarding the liver functional
classiﬁcation, the ChildePugh classiﬁcation was B in 17 patients
(3%) and A in 509 patients (97%), and the Japan’s liver damage
grade, including a parameter of indocyanine green (ICG) test, was
grade A in 454 patients (86%) and B in 72 (14%).
Table 1 shows the prevalence of SSI in the different periods. The
prevalence of superﬁcial SSI, deep SSI and the total number of SSIs
has not changed over an 18-year period.
Table 2 shows the demographics of patients who underwent
hepatectomy (for each SSI). In the deep SSI group, the male gender
was signiﬁcantly higher compared to other groups (p< 0.05). In the
deep SSI group, the prevalence of the lower performance status and
the lower American Society of Anesthesiologists (ASA) score were
signiﬁcantly higher compared with other groups (p < 0.05). Patient
age and the incidences of background liver, liver disease, co-
morbidity and preoperative liver functions were not signiﬁcantly
different between the groups.
Table 3 shows the surgical records and patient outcomes. The
incidences of laparoscopic hepatectomy tended to be higher and no
laparoscopic hepatectomy were observed in the SSI groups, but
these results were not signiﬁcant (p ¼ 0.102). The operators and
extend of the hepatectomies and combined resections were not
different between the groups. Non-use of hemostatic devices was
signiﬁcantly more frequent in the superﬁcial SSI group compared to
the other groups (p < 0.05). The operating and transection times
were not different between groups. Blood loss and transfusion
occurred signiﬁcantly more frequently in the deep SSI group
compared to the other groups, and the red cell transfusion rate in
the deep SSI group was signiﬁcantly higher compared to the other
groups (p < 0.01).
Hospitalization time in the deep SSI group was signiﬁcantly
longer compared to the other groups. The incidence of total post-
operative morbidity was more frequent in the superﬁcial and deep
SSI groups compared to the non-SSI group (p < 0.001). The in-
cidences of hepatectomy-related complications, hepatic failures,
long-term ascites, bile leakage and hospital stay deaths in the deep
SSI groups occurred signiﬁcantly more frequently compared to the
other groups (p < 0.01). Table 4 shows the risk ratio of the SSI-
associated parameters according to the multivariate analysis. Use
of the vessel sealing device was signiﬁcantly associated with su-
perﬁcial SSIs (p < 0.01). Male gender was signiﬁcantly associated
with deep SSIs (p < 0.05), but general status and surgical records
were not associated with deep SSIs. With respect to post-hepa-
tectomy complications, hepatic failure and bile leakage were
signiﬁcantly associated with deep SSIs (p < 0.05).
Table 2
Patient demographics, co-morbidity, general status and liver functional parameters
in patients with or without SSI.
Non-SSI
(n ¼ 420)
Superﬁcial
SSI (n ¼ 32)
Deep SSI
(n ¼ 74)
Statistics
(p value)
Age (years) 64.1  11.9 64.5  11.7 64.9  10.5
Gender
Male/female 293/127 16/16 58/16 0.014
Background liver
Normal/fatty/
viral/obstructive
jaundice
210/14/176/20 16/2/1/13/2 31/2/34/7 0.710
Liver diseases
Benign/HCC or
ICC/MLC/BTC
14/210/
135/52/9
0/19/8/2/3 2/37/23/12/0 0.122
Obesity (BMI > 25)
No/yes 293/127 21/11 49/25 0.759
Diabetes
No/yes 316/104 27/5 57/17 0.490
Cardiovascular diseasesa
No/yes 401/19 28/4 65/9 0.095
Renal diseases
No/yes 412/8 30/2 71/3 0.199
Performance status
0/1 394/26 27/5 64/10 0.022
ASA physiological statusb
1/2/3 256/147/17 20/7/5 41/27/6 0.030
Liver function tests
ChildePugh
classiﬁcation (A/B)
405/15 31/1 73/1 0.609
Liver damage
grade (A/B)
357/63 27/5 70/4 0.085
ICGR15 (%) 13.7  9.9 14.2  9.3 11.3  7.1
LHL15 0.92  0.05 0.92  0.03 0.93  0.03
Total bilirubin (mg/dl) 1.1  1.1 0.9  0.3 1.2  0.9
Prothrombin activity (%) 93  14 90  13 94  13
Platelet counts (/mm3) 20  10 18  10 20  7
Hyaluronic acid (ug/ml) 130  130 190  261 136  262
HCC, hepatocellular carcinoma; ICC, intrahepatic cholangiocarcinoma; MLC, meta-
static licer carcinoma; BTC, biliary tract carcinoma; BMI, body mass index.
*p < 0.05 vs. group 1. **p < 0.01 vs. group 2 and 3.
a Except hypertension.
b American Society of Anesthesiologists; ICGR15, indocyanine green retention
rate at 15 min; LHL15, liver uptake ratio by Tc GSA liver scintigraphy at 15 min.
Table 3
Relationship between surgical records or patient outcomes and SSI in patients un-
dergoing hepatectomy.
Non-SSI
(n ¼ 420)
Superﬁcial
SSI (n ¼ 32)
Deep
SSI (n ¼ 74)
Statistics
(p value)
Operator
Teaching staff/
fellow or resident
282/138 21/11 58/16 0.160
Incision
Laparoscopic/
abdominal/
thoraco-abdominal
19/335/66 0/26/6 0/56/18 0.102
Extend of hepatectomy
Partial/segment,
section/hemiliver,
more
140/124/156 6/13/13 22/24/28 0.478
Combined resection
of other organs
(no/yes)
342/78 25/7 59/15 0.861
Biliary reconstruction
(no/yes)
349/71 30/2 66/8 0.137
Combined vascular
resection (no/yes)
380/40 26/6 66/8 0.250
Use of hemostatic
devices (no/Yes)
98/322 14/18 16/58 0.029
Operating time (min) 419  166 445  199 422  232
Transection time (min) 47  20 43  11 48  24
Blood loss (ml) 984  886 788  566 1500  1001**
Red cell transfusion (ml) 303  661 194  342 567  611**
Transfusion (no/yes) 296/124 21/11 34/40 0.002
Hospital stay (days) 18  14 23  14 48  38**
Total complication
(no/yes)
278/142 1/31 3/71 <0.001
Hepatectomy-related
complication
(no/yes)
342/78 26/6 36/38 <0.001
Hepatic failure
(no/yes)
408/12 32/0 62/12 <0.001
Long-term ascites
(no/yes)
363/57 27/5 55/19 0.048
Bile leakage (no/yes) 401/19 32/0 49/25 <0.001
Hospital death (no/yes) 411/9 32/0 68/6 0.011
**p < 0.01 vs. non-SSI and superﬁcial SSI.
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Surgical site infection is a major postoperative complication,
particularly in hepatobiliary surgery [1,3,7]. This frustrating
complication prolongs hospital stays. SSI treatments have been
improved by the development of perioperativemanagement but not
theuseof antibiotics. A recent surgical report still has concerns about
SSIs. Arikawa et al. recently reported on each incisional and organ/
space SSI; the predictive factors for SSIs in HCC patients were longer
operations and bile leakage [1]. Thus, it is necessary to evaluate SSIs
separately in the superﬁcial (incisional) and deep (organ space) site,
in the present study as well. In this report, we examined hepatec-
tomies in patients with various liver diseases because we wanted to
examine different hepatectomy surgeries, such as combined resec-
tion of the bile duct, major vessels or other organs.
As postoperative complications might improve based on time
period changes, we conﬁrmed differences in the prevalence of SSI
based on our experiences. However, the incidence of each SSI did
not changed in 3 time periods over 18 years. Therefore, with respect
to SSIs at our institute, improvement could not be observed. Pre-
vious reports have shown an SSI incidence of approximately 10e
15% after hepatectomy; the incidence in the present series (5e8%)
was lower than these reports [1e3]. Therefore, our SSImanagement
might be adequate. With respect to preventing postoperative
infection, prophylactic antibiotics, such as kanamycin, were
administered orally for a couple of days before the operation, andthird-generation cephem antibiotics by drip infusion were used for
7 days after hepatectomies in the 1990s in our series. However,
these prophylaxes might not be necessary because reliable evi-
dence regarding their effectiveness has not been fully elucidated;
therefore, we have not administered prophylactic antibiotics since
2000. As a result, the incidence of infection was not changed at all.
Shaving of the body hair has been performed previously to prevent
incisional SSI at our institute. However, this procedure has also
been stopped since 2002 because the reliable evidence has not
been clariﬁed. Since 2004, ties with silk saw have been changed to
absorbable materials to prevent SSIs at our institute. When the
abdominal wound was closed, we fully wash the intra-abdominal
space with a large amount of saline (5000 ml) to remove remain-
ing microorganisms and the incised wound was well washed by a
jet stream of saline. With respect to the deep SSI, management of
drainage tube is important. In fact, we applied the closed drainage
tube and, however, the remarkable management regimen has not
been established at our institute. Thus, this management was
entrusted by each surgeon for the entire series in the present study.
The deep SSI was often conﬁrmed by the infectious ﬂuid via the
drainage tube and others were conﬁrmed by the additional punc-
ture drainage. In the deep SSI group, such a drainage tube associ-
ated infections were included in the present series. Infections were
conﬁrmed by the bacteriological examination. Therefore, the
adequate regimen for management of the drainage tube at our
institute should be established.
Table 4
Relationship between associated parameters and the superﬁcial and deep SSI by the
multivariate logistic regression analysis.
Superﬁcial SSI Deep SSI
OR
(95% CI)
P value OR (95% CI) P value
Gender
Male vs. female 2.0 (0.98e4.4) 0.051
Performance status
1 vs. 0 1.9
(0.6e5.6)
0.248 1.83 (0.6e5.6) 0.287
ASA score
2, 3 vs. 1 1.1 (0.6e2.2) 0.780
Use of vessel sealing device
No vs. yes 3.1
(1.4e6.7)
0.004
Blood loss
1000 ml vs. <1000 ml 1.2 (0.5e3.0) 0.763
Blood transfusion
Yes vs. no 1.1 (0.4e2.8) 0.844
Hepatectomy related complication
Yes vs. no 1.9 (0.8e4.7) 0.177
Hepatic failure
Yes vs. no 3.3 (1e11.6) 0.049
Uncontrolled ascites
Yes vs. no 1.5 (0.9e2.4) 0.092
Bile leakage
Yes vs. no 4.8 (2.2e10.4) <0.001
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and both superﬁcial and deep SSIs were examined. Although older
age, background liver diseases, lower liver functions, or co-mor-
bidities before surgery were supposed to be important factors with
respect to SSI according to previous reports [3,8], these factors were
not signiﬁcantly associated with either superﬁcial or deep SSIs in
our series. Current or past histories of cardiovascular diseases
tended to be associated with superﬁcial and deep SSIs. Previous
reports showed the relationship between SSI and cardiovascular
disease; for example, patients with cardiovascular diseases often
had acute cholecystitis without stones [9]. Although the causes are
still unknown, the physiological stress from treatments, associated
vasculitis or organ ischemia might cause this condition [10]. Of the
various co-morbidities, this factor might be the factor most asso-
ciated with SSI, according to our results. The male gender was
signiﬁcantly associated with deep SSIs in the present study. It was
speculated that male patients have more various habits, such as
alcohol or smoking, compared with female patients, which might
affect the systemic organ dysfunctions. However, the mechanism
behind this gender difference has not been identiﬁed. In the pre-
sent study, the different characteristics of male patients compared
to female patients could not be examined with the present archives
at our institute. As in previous reports, the lower performance
status or ASA levels were signiﬁcantly associated with deep SSIs in
the present study [11]. Patients with these parameters might have
lowered immunity, based on worsened systemic physiological
functions.
With respect to the surgical records, the patients who under-
went laparoscopic operations did not experience any SSIs. Lapa-
roscopic operations for digestive organs were also associated with
lower infections, and the length of the surgical wound was related
to bacterial infections [12]. In particular, gram-positive bacteria,
such as a methicillin-resistance Staphylococcus aureus, was often
detected on the surface wound or around foreign objects, such as a
drainage tube [13]. Laparoscopic surgery for hepatic surgery has
recently increased worldwide, and developing this procedure is
necessary from the perspective of avoiding SSIs. Furthermore, the
use of hemostatic devices was associated with lower the superﬁcialSSI in the present study. By using such devices, contamination via
the operator’s ﬁgures or the spread of digestive juices on the
abdominal wall or skin might be avoided. Using vessel sealing de-
vices decreased bile leakage after hepatectomy in previous reports
as well [14]. In case of laparoscopic hepatectomy, the dissecting or
hemostatic devises were mainly used for parenchymal transec-
tions, whichmight be inﬂuenced the lower prevalence of SSIs in the
laparoscopic procedures. Forceps fracture method for open use was
considered as a risk factor for SSI via the operator’s hands or for-
ceps. Combined resections of the main vessel or biliary tract were
alleged SSI risk factors; however, a signiﬁcant relationship between
SSI and these procedures were not observed. In such operations, the
surgeons might be more careful about not contaminating the sur-
gical site. Blood loss and related red cell transfusions were signiﬁ-
cantly associated with deep SSIs in the present results. As in
previous reports, these factors inﬂuenced the increased morbidity
and patient prognosis in cancer patients with liver diseases [15,16].
Although the remarkable mechanisms of this phenomenon have
not been clariﬁed yet, decreased immunity caused by increased
blood loss or blood transfusionwas thought to be one cause [15,16].
In any event, preventing blood loss by using recent medical devices
or controlling transfusions during the operation would decrease
the prevalence of SSIs. From the results of the multivariate analysis,
non-use of hemostatic device is an independent prognostic factor
that may prevent superﬁcial SSIs. Such a devicewas preferably used
to cut the abdominal wall muscles or peritoneum in the recent
periods.
With respect to patient outcomes, SSIs frequently occurred
when any postoperative complications were observed. However,
superﬁcial SSIs were not signiﬁcantly associated with
hepatectomy-related complications and the length of hospital stay
in the present study. The appearance of superﬁcial SSIs was not
expected after the hepatectomies. However, deep SSIs were closely
associatedwith any hepatectomy-related severe complication, such
as hepatic failure or related hospital-stay death in particular. He-
patic failure frequently causes infection because of the deteriora-
tion of the immunological defense mechanism from bacterial
translocation or sepsis [17]. Long-term ascites after hepatectomy
may cause bacterial peritonitis [18]. Bile juice leakage often causes
intra-abdominal infection in the space, except for the drainage area
[1]. In the multivariate analysis, bile leakage was the most signiﬁ-
cant risk factor for deep SSI. Preventing bile leakage from the cystic
duct tube might be effective for avoiding SSI [19]. Such a surgical
procedure can decrease the occurrence of deep SSIs, and we
attempted to use cystic duct drainage tubes to decompress the
intra-biliary pressure in cases of anatomical hepatic resections [20].
Hospital-stay length was signiﬁcantly affected by the high preva-
lence of post-hepatectomy complications and deep SSIs. Deep SSI
was thought to be an important factor affecting patient survival
prognosis because this infection causes systemic sepsis and addi-
tional multi-organ dysfunctions. Thus, deep SSI is a risk factor for
patient outcomes and prolonged hospital stays. The present study
was a retrospectively cohort study, in which the present study
design might provide some bias in results. Therefore, it is necessary
to design a prospective randomized study in each subgroup in the
suture step.
In conclusion, it has been demonstrated the prevalence of su-
perﬁcial and deep SSIs and examined their effect in the surgical
records and outcomes of patients with various diseases who un-
derwent hepatic resections. SSI prevalence has not been changed in
18 years. Various factors were associated with each SSI, and the
multivariate analysis showed that non-use of hemostatic devices
and postoperative complications were associated with superﬁcial
SSIs, but hospital stays were not signiﬁcantly prolonged. Male
gender, hepatic failure and bile leakage were signiﬁcantly
A. Nanashima et al. / International Journal of Surgery 12 (2014) 310e314314
ORIGINAL RESEARCHassociated with deep SSIs. Preventing bile leakage with surgical
procedures should be important for improving the prevalence of
SSIs, and such attempts may decrease patient outcomes after
hepatectomy.
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